Cargando…
Honokiol in glioblastoma recurrence: a case report
Glioblastoma is the most common and aggressive primary tumor in the central nervous system. There is no standard of care for patients with recurrent GBM. Honokiol is a pleiotropic lignan and has the potential to be a potent and safe anticancer agent in human GBM when it is encapsulated by liposomes....
Autores principales: | Wang, Ce, Cai, Zehao, Huang, Yue, Liu, Xinrui, Liu, Xing, Chen, Feng, Li, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324972/ https://www.ncbi.nlm.nih.gov/pubmed/37426439 http://dx.doi.org/10.3389/fneur.2023.1172860 |
Ejemplares similares
-
Liposomal honokiol inhibits glioblastoma growth through regulating macrophage polarization
por: Li, Shenglan, et al.
Publicado: (2021) -
Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells
por: CHANG, KEN-HU, et al.
Publicado: (2013) -
Non-enhancing Glioblastoma: A Case Report
por: Park, Dahye, et al.
Publicado: (2023) -
Liposomal Honokiol induces ROS-mediated apoptosis via regulation of ERK/p38-MAPK signaling and autophagic inhibition in human medulloblastoma
por: Li, Shenglan, et al.
Publicado: (2022) -
Severe Recurrent Necrotizing Myopathy in Pregnancy: A Case Report
por: Li, Yue, et al.
Publicado: (2018)